title: Epstein-Barr virus-induced CD30-positive diffuse large B-cell lymphoma in a patient with mixed-phenotypic leukemia treated with clofarabine.
authors.affiliation: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Pavan Kumar
authors.initials: PK
authors.lastname: Bhamidipati
authors.forename: Elias
authors.initials: E
authors.lastname: Jabbour
authors.forename: Sergej
authors.initials: S
authors.lastname: Konoplev
authors.forename: Zeev
authors.initials: Z
authors.lastname: Estrov
authors.forename: Jorge
authors.initials: J
authors.lastname: Cortes
authors.forename: Naval
authors.initials: N
authors.lastname: Daver
mesh_terms: D000227:Adenine Nucleotides / Q000009:adverse effects / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001087:Arabinonucleosides / Q000009:adverse effects / Q000627:therapeutic use*; D000077866:Clofarabine; D020031:Epstein-Barr Virus Infections / Q000473:pathology / Q000821:virology*; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D017730:Ki-1 Antigen / Q000378:metabolism*; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D008297:Male; D008875:Middle Aged
chemical_list: D000227:Adenine Nucleotides; D000964:Antimetabolites, Antineoplastic; D001087:Arabinonucleosides; D017730:Ki-1 Antigen; D000077866:Clofarabine